Starling Oncology, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Starling Oncology, Inc. stock issued during period, shares, new issues for the quarter ending 2025-03-31 was 12.01M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-03-31 | 12.01M shares 10-Q · filed 2025-05-14 |